ANTONIOS SMAILIS

Dr. ANTONIOS SMAILIS

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
DSDimitrios Schizas
Dimitrios Schizas
DIMITRIOS SCHIZASDIMITRIOS SCHIZAS
DIMITRIOS SCHIZAS
DKDespoina Maria Karavolia
Despoina Maria Karavolia
ASANTONIOS SMAILIS
ANTONIOS SMAILIS
Nikolaos MachairasNikolaos Machairas
Nikolaos Machairas
GAGeorge Agrogiannis
George Agrogiannis
Synovial sarcoma (SS) is a rare mesenchymal entity that represents 5–10% among soft tissue sarcomas (STS). Primary renal synovial sarcoma (PRSS) is an uncommon, rapidly growing tumor, with potential metastatic dissemination. The main prognostic factors of PRSS include tumor size and histologic grade, while translocation t (X; 18) (p11.2; q11.2) (fusion of SYT gene -chromosome 18- with SSX genes (1, 2 or 4)-chromosome X) is the most common pathognomonic sign. Aggressive surgical resection of the tumor along with concomitant regional lymphadenectomy is the treatment of choice for PRSS, while additional en bloc resection of the adjacent affected organs is often performed. To date, the role of preoperative or postoperative chemotherapy remains equivocal. The prognosis of patients with PRSS is poor, as the 5-year survival rate is only 20–30% and further deteriorates when a high mitotic activity is detected. Local recurrence even after complete R0 surgical excision remains the most frequent cause of death. The aim of this review was to meticulously discuss clinical features, histogenesis, and morphological and immunochemical findings of PRSS, while the role of current diagnostic and therapeutic management of this aggressive neoplasm was emphasized.

30 August 2019 in Proceedings
Verified
Conference Paper
Open access
PDF file
CCCostas Chryssanthopoulos
Costas Chryssanthopoulos
MAMichaella Alexandrou
Michaella Alexandrou
MHMaria Horianopoulou
Maria Horianopoulou
ISIoannis Alexandros Stogios
Ioannis Alexandros Stogios
PIParaskevas Ioannou
Paraskevas Ioannou
APAnastassios Philippou
Anastassios Philippou
AIM: There is some evidence to suggest that exercise in the evening, compared with exercise in the morning, has a more beneficial impact on glycemia in patients with type 2 diabetes (T2D). The aim of this study was to examine a possible acute effect of aerobic exercise performed at different times of day on blood glucose levels during and after exercise in patients with T2D. MATERIAL & METHOD: Eight male T2D patients (61.8 ± 6.9 yrs, 27.7 ± 3.1 kg/m2, HbA1c: 6.5 ± 1.1%; mean ± SD), who did not receive insulin, performed 60-min cycling at about 75% maximal heart rate (HRmax) either at 10:30 (Morning-M), or at 17:30 (Evening-E), or 30-min cycling at 10:30 and 30-min cycling at 17:30 (ME). A control condition (C) was also included where volunteers did not exercise but had their blood glucose measured at day-time intervals similar to the time intervals of the three exercise trials. Two days before each condition no physical activity was allowed, while the day before and on the day of each trial participants controlled their diet. RESULTS: Compared to resting levels, blood glucose at the end of exercise decreased at similar levels in M (20 ± 12%), E (28 ± 14%), in the morning of ME (21 ± 10%) and in the evening of ME (26 ± 19%) (p > 0.05). Also, heart rate, blood lactate and rate of perceived exertion responses during exercise were similar between the 3 exercise conditions. Mean area under the blood glucose-time curve over the two-hour post-exercise period in exercise trials, and at similar time intervals in C, was different only between the morning in C (15,173 ± 1830 mg/dL•120 min) and the evening in ME (11,681 ± 1526 mg/dL•120 min, p = 0.045). In addition, overnight fasting serum glucose the morning after each trial was similar between conditions (p > 0.05). CONCLUSIONS: No acute effect of cycling at about 75% HRmax was observed on glycemia in patients with T2D when exercise was performed at different times of day.